Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical Co., Ltd.

CHGCY
Chugai Pharmaceutical Co., Ltd.US flagOther OTC
23.37
USD
+1.07
- -
76.92BMarket Cap

Valuation

Price vs. fair value · multiples
Price & Valuation BandSIGNATURE
Price against a fair-value channel (EPS × 12 / 15 / 23×)
+14.4% CAGRUndervalued -99%
PriceFair value

Growth

Revenue · EPS · free cash flow
Revenue
Top line with YoY growth
RevenueYoY growth
Premium metric

Fundamentals for companies outside the US are part of Premium.

EPS (Diluted)
Per-share earnings · loss years read red
EPSYoY growth
Premium metric

Fundamentals for companies outside the US are part of Premium.

Free Cash Flow
Operating CF − capex, with FCF margin
Operating CFCapexFree cash flowFCF margin
Premium metric

Fundamentals for companies outside the US are part of Premium.

Profitability

Margins & returns on capital
Gross Profit & Margin
Bars with margin trend line
Gross profitGross margin
Premium metric

Fundamentals for companies outside the US are part of Premium.

Operating Income & Margin
Bars with margin trend line
Operating incomeOperating margin
Premium metric

Fundamentals for companies outside the US are part of Premium.

Net Income & Margin
Loss years read red
Net incomeNet margin
Premium metric

Fundamentals for companies outside the US are part of Premium.

ROIC · ROE · ROA
Returns on capital · ROE on right axis
ROICROEROA
Premium metric

Fundamentals for companies outside the US are part of Premium.

Balance Sheet Health

Liquidity · leverage · share count
Cash vs. Debt
Liquidity & leverage, net-debt line
Cash & investmentsTotal debtNet debt
Premium metric

Fundamentals for companies outside the US are part of Premium.

Shares Outstanding
Diluted share count · buybacks vs. dilution
Premium metric

Fundamentals for companies outside the US are part of Premium.

Dividends & Payout Ratio
Dividend per share with payout overlay
Dividend / sharePayout ratio
Premium metric

Fundamentals for companies outside the US are part of Premium.

roic.ai · Fundamentals charts. Figures are not investment advice.